DIAGNOSTIC VALUE OF ACR O-RADS MRI v.2024 IN DIFFERENTIATING BENIGN AND MALIGNANT ADNEXAL MASSES
Main Article Content
Abstract
Background: The Ovarian-Adnexal Reporting and Data System for MRI (O-RADS MRI, version 2024) developed by the American College of Radiology (ACR) provides a standardized framework for risk stratification of adnexal masses. While validated internationally, its application in Vietnam remains limited. Purpose: To evaluate the correlation between O-RADS MRI categories and histopathological outcomes of ovarian tumors, and to identify MRI features predictive of malignancy. Materials and Methods: This retrospective study included 63 ovarian lesions from 57 patients who underwent preoperative pelvic MRI with histopathological confirmation between January 2023 and July 2025. Results: Eighteen of 63 lesions (28.6%) were malignant, including invasive ovarian carcinoma (n=11), ovarian metastasis from gastric carcinoma (n=1) and borderline tumors (n=6). The presence of strongly enhancing solid tissue was the strongest predictor of malignancy (OR = 35.6; 95% CI: 4.15–304.7; p=0.001). An O-RADS MRI cutoff of ≥4 achieved a sensitivity of 78% and specificity of 93%, with an AUC of 0.884. Malignancy rates increased across O-RADS categories: 2 (0%), 3 (14.3%), 4 (75%), and 5 (80%). Conclusion: O-RADS MRI demonstrates high diagnostic accuracy in differentiating benign from malignant adnexal masses. The assessment of enhancing solid tissue is particularly valuable for predicting malignancy and guiding management.
Keywords
O-RADS MRI; Adnexal mass; Ovarian cancer; Malignancy prediction.
Article Details
References
2. Sadowski EA, Thomassin-Naggara I, Rockall A, Maturen KE, Forstner R, Jha P, et al. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee. Radiology. 2022 Apr;303(1):35–47.
3. Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020 Jan;294(1): 168–85.
4. American College of Radiology. O-RADSTM MRI Risk Stratification and Management System. Reston (VA): American College of Radiology; https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Reporting-and-Data-Systems/O-RADS/MRI
5. Sadowski EA, Stein EB, Thomassin-Naggara I, Rockall A, Nougaret S, Reinhold C, et al. O-RADS MRI After Initial Ultrasound for Adnexal Lesions: AJR Expert Panel Narrative Review. Am J Roentgenol. 2023 Jan;220(1):6–15.
6. Mitchell S, Gleeson J, Tiwari M, Bailey F, Gaughran J, Mehra G, et al. Accuracy of ultrasound, magnetic resonance imaging and intraoperative frozen section in the diagnosis of ovarian tumours: data from a London tertiary centre. BJC Rep. 2024 July 2;2(1):50.
7. Kılıçkap G. Diagnostic performance of the O-RADS MRI system for magnetic resonance imaging in discriminating benign and malignant adnexal lesions: a systematic review, meta-analysis, and meta-regression. Diagn Interv Radiol. 2024 July 8; https://dirjournal.org/articles/ doi/dir.2024.242784
8. Thomassin-Naggara I, Belghitti M, Milon A, Abdel Wahab C, Sadowski E, Rockall AG, et al. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort. Eur Radiol. 2021 Dec;31(12):9588–99.
9. Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, Guerra A, Fournier LS, Stojanovic S, et al. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses. JAMA Netw Open. 2020 Jan 24;3(1):e1919896.